Eur Respir J 2008, doi:10.1183/09031936.00087708
LBP and CD14 are increased in the bronchoalveolar lavage fluid of smokers
1 Centro Investigación Biomédica en Red de Enfermedades Respiratorias (CibeRes), Bunyola; and Program Infection and Immunity, Fundación Caubet-CIMERA Illes Balears, Bunyola
* To whom correspondence should be addressed. E-mail: bengoechea{at}caubet-cimera.es.
Lipopolysaccharide-binding protein (LBP) and CD14 contribute to the recognition of pathogens by cells which triggers the activation of defence responses. Smoking is a risk factor for the development of chronic obstructive pulmonary disease (COPD) and infections. We theorized that levels of LBP and CD14 in the lungs from smokers would be higher than those in the lungs from never smokers. These elevated levels could affect host responses upon infection. LBP, sCD14, IL-8 were detected by ELISA. NF- Broncho-alveolar lavage levels of LBP and CD14 were significantly higher in smokers and COPD patients than in never smokers whereas levels of both proteins were not significantly different in smokers and COPD patients. IL-6 and IL-1 Thus, in the inflamed airways of smokers both proteins could contribute to inhibit bacteria-dependent cellular activation without compromising the internalisation of pathogens by airway cells. Keywords: LBP-CD14-INFLAMMATION-HAEMOPHILUS
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||